ProQR Therapeutics NV (PRQR)
1.435
+0.02
(+1.77%)
USD |
NASDAQ |
Jun 11, 16:00
1.435
0.00 (0.00%)
After-Hours: 18:14
ProQR Therapeutics Total Assets (Quarterly) : 114.11M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 114.11M |
| December 31, 2025 | 132.43M |
| September 30, 2025 | 146.11M |
| June 30, 2025 | 161.45M |
| March 31, 2025 | 163.85M |
| December 31, 2024 | 173.92M |
| September 30, 2024 | 119.25M |
| June 30, 2024 | 126.52M |
| March 31, 2024 | 133.79M |
| December 31, 2023 | 152.31M |
| September 30, 2023 | 150.38M |
| June 30, 2023 | 161.46M |
| March 31, 2023 | 171.67M |
| December 31, 2022 | 182.84M |
| September 30, 2022 | 119.26M |
| June 30, 2022 | 187.19M |
| March 31, 2022 | 211.66M |
| December 31, 2021 | 238.33M |
| September 30, 2021 | 226.38M |
| June 30, 2021 | 192.54M |
| March 31, 2021 | 107.67M |
| December 31, 2020 | 120.80M |
| September 30, 2020 | 129.22M |
| June 30, 2020 | 105.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 113.71M |
| December 31, 2019 | 131.93M |
| September 30, 2019 | 88.38M |
| June 30, 2019 | 102.78M |
| March 31, 2019 | 114.11M |
| December 31, 2018 | 126.01M |
| September 30, 2018 | 138.21M |
| June 30, 2018 | 43.83M |
| March 31, 2018 | 51.98M |
| December 31, 2017 | 63.77M |
| September 30, 2017 | 53.90M |
| June 30, 2017 | 55.19M |
| March 31, 2017 | 62.17M |
| December 31, 2016 | 69.13M |
| September 30, 2016 | 81.84M |
| June 30, 2016 | 93.25M |
| March 31, 2016 | 104.15M |
| December 31, 2015 | 108.75M |
| September 30, 2015 | 116.96M |
| June 30, 2015 | 123.71M |
| March 31, 2015 | 126.29M |
| December 31, 2014 | |
| September 30, 2014 | 147.33M |
| June 30, 2014 | 53.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pharming Group NV | 489.36M |
| NewAmsterdam Pharma Co. NV | 732.64M |
| Kamada Ltd. | 383.02M |
| Syndax Pharmaceuticals, Inc. | 472.67M |
| Opus Genetics, Inc. | 66.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 70.79M |
| Shareholders Equity (Quarterly) | 43.32M |
| Debt to Equity Ratio | 0.364 |
| Current Ratio | 2.481 |
| Net Debt Paydown Yield | 0.04% |